Blog Archives

PRESS RELEASE: $1.5M NIH Funding To Expand Parkinson’s Telemedicine To Mobile Apps

VIEW PRESS RELEASE 15 APR 2014: Valley View, OH – Great Lakes NeuroTechnologies (GLNT) announced today they will be using a $1.5M award from NIH to expand their Parkinson’s monitoring technology to mobile applications. Repositioning GLNT’s Kinesia™ product line with mobile apps strategically aligns with growing trends in domestic and

Read more ›


PRESS RELEASE: Great Lakes NeuroTechnologies Continues Intellectual Property Growth As New Patent Claims Focus On Parkinson’s Device Accuracy And Sensitivity

VIEW PRESS RELEASE 05 MAR 2014: Valley View, OH – Great Lakes NeuroTechnologies announced today they have received a new allowance of claims from the U.S. Patent Office, the company’s fourth in the past eight months focused on technology for Parkinson’s disease diagnostics and treatment.


Clinician Versus Machine: Reliability and Responsiveness of Motor Endpoints in Parkinson’s Disease

D. Heldman, A. Espay, P. Lewitt, and J. Giuffrida Parkinsonism Relat Disord. 2014;20(6):590–5.


PRESS RELEASE: Great Lakes NeuroTechnologies Launches Study to Automatically Classify Abnormal Muscle Tone in Movement Disorders

VIEW PRESS RELEASE [PDF] 15 JAN 2014: Valley View, OH – Great Lakes NeuroTechnologies (GLNT) announced today that it is launching a study to determine the feasibility of a clinician-worn glove to objectively evaluate abnormal muscle tone, such as stiff joints or muscle tightness, due to neurological disorders.


Continuous In-Home Monitoring Of Essential Tremor

C. Pulliam, S. Eichenseer, C. Goetz, O. Waln, C. Hunter, J. Jankovic, D. Vaillancourt, J. Giuffrida, And D. Heldman Parkinsonism Relat Disord. 2014 Jan;20(1):37-40.


Tradeshow Event: Partnership in Clinical Trials

The Mirage Hotel Las Vegas, NV March 31 – April 2 2014 Conference home page We will be exhibiting at booth #1305 . We will be demonstrating out Kinesia HomeView and ProView systems. From the 2013 event: This year’s event brings together upwards of 1300 clinical decision makers for four

Read more ›


WKSU Exploradio: Measuring progress in Parkinson’s research

Sunday, November 10, 2013 WKSU’s Jeff St. Clair recently visited our offices and met with Dr. Dustin Heldman, Sr. BME Researcher, and Ms. Maureen Phillips, Sales Manager. The three had some great talks about alternative and innovatives therapies for Parkinson’s patients, and also the great strides our Kinesia system is

Read more ›


PRESS RELEASE: GLNT Expanding Telemedicine Technology for Parkinson’s Disease

VIEW PRESS RELEASE [PDF] 05 Sept 2013: Valley View, OH – Great Lakes NeuroTechnologies (GLNT) announced today they are launching commercialization and clinical studies to expand their telemedicine technology, Kinesia HomeView™ [ http://glneurotech.com/kinesia/homeview/ ], for individuals with Parkinson’s disease by adding real-time video conferencing. The research and development are being

Read more ›


PRESS RELEASE: Kinesia ProView Launches to Visualize Parkinson’s Symptom Response to Deep Brain Stimulation Programming

VIEW PRESS RELEASE [PDF] 15 MAY 2013: Valley View, OH – Great Lakes NeuroTechnologies announced today the product launch of Kinesia ProView™ [ http://www.glneurotech.com/kinesia/proview/index.php ] to visualize motor symptom severity response during programming of deep brain stimulation (DBS) for Parkinson’s disease. Kinesia ProView provides a standardized platform to quantitatively assess

Read more ›


PRESS RELEASE: Great Lakes NeuroTechnologies’ Kinesia Technology Receives TGA Approval for Parkinson’s Assessment in Australia

VIEW PRESS RELEASE [PDF] 9 JAN 2013: Valley View, OH – Great Lakes NeuroTechnologies announced today that they received TGA approval to market Kinesia technology in Australia. The Kinesia™ product line [ http://glneurotech.com/kinesia/ ] includes patient-worn motion sensors and a tablet computer to quantitatively assess tremor, bradykinesia, and dyskinesia associated

Read more ›